Glycemic control is essential for preventing major complications in individuals with type 2 diabetes (T2D) 1,2,3. Over the past decade, glycemic control has declined substantially in the United States ...
Achieving optimal glycemic control remains challenging for many individuals with type 1 diabetes using multiple daily injections. We report results from a 12-week, open-label, randomized controlled ...
New data-driven approaches change how researchers evaluate experimental therapies in clinical trials. Among these, synthetic control arms use existing datasets to provide a flexible framework for ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results